Cargando…

Increased body sway in phobic patients exposed to images of spiders

OBJECTIVE: The aim of the present study was to analyze the body sway response in specific phobia (SP) patients and healthy controls while viewing neutral, phobic, and disgusting images. METHODS: The participants’ heart rate (HR) and skin conductance were also recorded during the procedure. Nineteen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linares, Ila M.P., Nardi, Antonio E., Guimarães, Francisco S., Arrais, Katia C., Chagas, Marcos H., Osório, Flavia L., Hallak, Jaime E., Zuardi, Antonio W., Coimbra, Norberto C., Crippa, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555649/ https://www.ncbi.nlm.nih.gov/pubmed/33331404 http://dx.doi.org/10.1590/1516-4446-2020-1466

Ejemplares similares

Nonlinear Variability of Body Sway in Patients with Phobic Postural Vertigo
por: Schniepp, Roman, et al.
Publicado: (2013)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

Spider phobics more easily see a spider in morphed schematic pictures
por: Kolassa, Iris-Tatjana, et al.
Publicado: (2007)

Event-related potentials when identifying or color-naming threatening schematic stimuli in spider phobic and non-phobic individuals
por: Kolassa, Iris-Tatjana, et al.
Publicado: (2006)

Specificity of spiders among fear- and disgust-eliciting arthropods: Spiders are special, but phobics not so much
por: Landová, Eva, et al.
Publicado: (2021)

Changes in facial electromyographic activity in spider-phobic girls after psychotherapy
por: Leutgeb, Verena, et al.
Publicado: (2012)

Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930–March 9, 2023) and his legacy for Brazilian pharmacology
por: Crippa, José Alexandre S., et al.
Publicado: (2023)

Marijuana, feijoada and the debate on drug legalization
por: Crippa, José A. S., et al.
Publicado: (2013)

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
por: Linares, Ila M., et al.
Publicado: (2018)

Varying expectancies and attention bias in phobic and non-phobic individuals
por: Aue, Tatjana, et al.
Publicado: (2013)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022)

Exposure therapy leads to enhanced late frontal positivity in 8- to 13-year-old spider phobic girls
por: Leutgeb, Verena, et al.
Publicado: (2012)

Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature
por: Crippa, José AS, et al.
Publicado: (2012)

Monitoring the Mental Health and Professional Overload of Health Workers in Brazil: A Longitudinal Study Considering the First Wave of the COVID-19 Pandemic
por: Osório, Flávia L., et al.
Publicado: (2022)

Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study
por: Loureiro, Sonia Regina, et al.
Publicado: (2023)

Workplace Protections and Burnout Among Brazilian Frontline Health Care Professionals During the COVID-19 Pandemic
por: Pereira-Lima, Karina, et al.
Publicado: (2022)

Fat-Phobic and Non-Fat-Phobic Anorexia Nervosa: A Conjoint Analysis on the Importance of Shape and Weight
por: Korn, Julia, et al.
Publicado: (2020)

Risk and Protective Factors for the Mental Health of Brazilian Healthcare Workers in the Frontline of COVID-19 Pandemic
por: Osório, Flávia L., et al.
Publicado: (2021)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
por: Zuardi, Antonio W., et al.
Publicado: (2017)

Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder
por: De Morais, E. R., et al.
Publicado: (2023)

Heritability of Self-reported Phobic Fear
por: Distel, Marijn A., et al.
Publicado: (2007)

Current management of obsessive and phobic states
por: Goljevscek, Serena, et al.
Publicado: (2011)

How emotions affect logical reasoning: evidence from experiments with mood-manipulated participants, spider phobics, and people with exam anxiety
por: Jung, Nadine, et al.
Publicado: (2014)

Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021)
por: de Lima Osório, Flávia, et al.
Publicado: (2023)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Late cortical positivity and cardiac responsitivity in female dental phobics when exposed to phobia-relevant pictures
por: Leutgeb, Verena, et al.
Publicado: (2011)

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

Performance of Polygenic Scores for Predicting Phobic Anxiety
por: Walter, Stefan, et al.
Publicado: (2013)

Network changes in patients with phobic postural vertigo
por: Huber, Judita, et al.
Publicado: (2020)

COVID-19: Do not be phobic from fever
por: Galdiero, Massimiliano, et al.
Publicado: (2020)

Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
por: Crippa, José A., et al.
Publicado: (2018)

Reducing the Meta-Emotional Problem Decreases Physiological Fear Response during Exposure in Phobics
por: Couyoumdjian, Alessandro, et al.
Publicado: (2016)

Comprehensive and esthetic rehabilitation for phobic patient “case report”
por: Fahad AlEidan, Razan, et al.
Publicado: (2019)

Method for Assessing the Influence of Phobic Stimuli in Virtual Simulators
por: Obukhov, Artem, et al.
Publicado: (2023)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
por: Souza, José Diogo S., et al.
Publicado: (2022)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
por: Vuolo, Francieli, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jph0o55nk4j18gbfvrr13337s8